Great, another pilot study and another indication where one the RCE antibiotics might be beneficial.
Unfortunately, without a proper phase 2 follow up, one that follows a protocol that the FDA will accept, all these pilots and phase 1 studies are useless and a waste of time and resources.
I'd be much happier if RCE for once selects an indication and proceed with and completes a P2 study. The way things move along (I.e. side ways) at the moment does not help bringing a product to market. Moreover, it eats away from the patent protection period.
Not happy with the current lack of direction
Great, another pilot study and another indication where one the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
0.003(0.69%) |
Mkt cap ! $104.8M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 39.5¢ | 36.0¢ | $72.04K | 191.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46885 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 1245 | 1 |
View Market Depth
| Last trade - 15.58pm 23/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |